Bloomberg -- Horizon Therapeutics Inc., a U.S. developer of pain medications, is close to an agreement to buy Switzerland’s Nitec Pharma AG, said a person with knowledge of the transaction.
Bloomberg -- Horizon Therapeutics Inc., a U.S. developer of pain medications, is close to an agreement to buy Switzerland’s Nitec Pharma AG, said a person with knowledge of the transaction.